01 / 03 / 2020 | Birgit Schilling
The length of time we remain in good health is the focus of Birgit Schilling and the team at the Buck Institute for Research on Aging. The team’s mass spectrometry-based proteomics studies use data independent acquisition to look for biomarkers of aging and age-related diseases that can threaten an individual’s health span. The researchers see a future where non-invasive tests enable early intervention and the preservation of health.
“I would like you, maybe in 20 years, [to] feel just as healthy as you hopefully feel today.”